HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guo-Qing Wang Selected Research
Guo-Qing Wang Research Topics
Disease
11
Neoplasms (Cancer)
04/2016 - 02/2003
6
Inflammation (Inflammations)
12/2022 - 01/2017
5
Parkinson Disease (Parkinson's Disease)
12/2021 - 01/2017
4
Esophageal Squamous Cell Carcinoma
05/2014 - 01/2009
4
Esophageal Neoplasms (Esophageal Cancer)
01/2012 - 12/2002
3
Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021 - 01/2016
3
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2017
3
Carcinoma (Carcinomatosis)
05/2013 - 02/2003
2
Alzheimer Disease (Alzheimer's Disease)
01/2021 - 03/2020
2
Gliosis
09/2019 - 01/2019
2
Stomach Neoplasms (Stomach Cancer)
05/2014 - 05/2013
2
Vesicular Stomatitis
10/2008 - 03/2007
1
Hemorrhage
12/2022
1
COVID-19
01/2022
1
Type 2 Diabetes Mellitus (MODY)
01/2022
1
Diabetes Mellitus
01/2022
1
AIDS-Related Complex (ARC)
10/2021
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1
Dementia (Dementias)
01/2021
1
Cognitive Dysfunction
03/2020
1
Neuroinflammatory Diseases
01/2020
1
Carcinogenesis
01/2018
1
Dyskinesias (Dyskinesia)
01/2018
1
Ischemia
01/2017
1
Hepatocellular Carcinoma (Hepatoma)
01/2017
1
Renal Cell Carcinoma (Grawitz Tumor)
04/2016
1
Healthcare-Associated Pneumonia
01/2016
1
Pneumonia (Pneumonitis)
01/2016
1
Membranous Glomerulonephritis (Membranous Nephropathy)
01/2016
1
Shock
01/2015
1
Adenocarcinoma
05/2013
1
Alopecia (Baldness)
01/2013
1
Lactose Intolerance (Intolerance, Lactose)
06/2012
1
Aneuploidy (Aneuploid)
01/2012
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
01/2022 - 03/2007
5
Dopamine (Intropin)
FDA Link
Generic
12/2021 - 01/2017
4
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 04/2010
3
Vaccines
IBA
01/2022 - 03/2020
3
Antioxidants
IBA
01/2020 - 01/2013
3
Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)
IBA
09/2009 - 12/2002
2
Ellagic Acid
IBA
01/2020 - 09/2019
2
Messenger RNA (mRNA)
IBA
01/2019 - 01/2015
2
Pepsinogen A (Pepsinogen)
IBA
05/2014 - 01/2009
2
Pepsinogen C
IBA
05/2014 - 01/2009
2
Paraffin
IBA
07/2010 - 03/2004
2
Coloring Agents (Dyes)
IBA
11/2007 - 05/2004
2
Iodine
IBA
05/2004 - 02/2003
1
necrostatin-1
IBA
12/2022
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
12/2022
1
Streptozocin (Streptozotocin)
FDA Link
01/2022
1
Antiviral Agents (Antivirals)
IBA
01/2022
1
Amyloid (Amyloid Fibrils)
IBA
01/2021
1
Inflammasomes
IBA
01/2020
1
Neuroprotective Agents
IBA
01/2020
1
NLR Proteins
IBA
01/2020
1
4-iodobenzenesulfonamide
IBA
12/2019
1
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
09/2019
1
Small Interfering RNA (siRNA)
IBA
01/2019
1
Nerve Growth Factors (Neurotrophins)
IBA
01/2019
1
Levodopa (L Dopa)
FDA Link
Generic
01/2018
1
Electron Transport Complex I (NADH-CoQ Reductase)
IBA
01/2018
1
Protease La (Endopeptidase La)
IBA
01/2018
1
mitochondrial transcription factor A
IBA
01/2018
1
Aconitate Hydratase (Aconitase)
IBA
01/2018
1
Pharmaceutical Preparations
IBA
01/2018
1
Rotenone
IBA
01/2017
1
Adenosine Triphosphatases (ATPase)
IBA
01/2017
1
Lipopolysaccharides
IBA
01/2017
1
icariin
IBA
01/2017
1
epimedii flavone
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
04/2016
1
Carboxypeptidases
IBA
04/2016
1
Staphylococcal Protein A (Protein A)
IBA
04/2016
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2016
1
Autoantibodies
IBA
01/2016
1
Immunoglobulin G (IgG)
IBA
01/2016
1
Antigens
IBA
01/2016
1
Interleukin-27 (Interleukin 27)
IBA
01/2016
1
Phospholipase A2 Receptors
IBA
01/2016
1
Lugol's solution (Lugol's iodine)
IBA
06/2015
1
Thiobarbituric Acid Reactive Substances
IBA
01/2015
1
Renin
IBA
01/2015
1
Corticosterone
IBA
01/2015
1
Captopril (Capoten)
FDA Link
Generic
01/2015
1
Superoxide Dismutase
IBA
01/2015
1
Angiotensinogen
IBA
01/2015
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2015
1
tempol
IBA
01/2015
1
4-vinyl-2,6-dimethoxyphenol
IBA
05/2013
1
thiazolyl blue
IBA
05/2013
1
Galactosidases
IBA
06/2012
Therapy/Procedure
6
Therapeutics
01/2022 - 03/2007
1
Oral Administration
01/2022
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021
1
Immunotherapy
03/2020
1
Chemoradiotherapy
12/2019
1
Radiotherapy
12/2019
1
Drug Therapy (Chemotherapy)
01/2018
1
Hepatectomy
01/2017
1
Denervation
01/2015